Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00202293
What this trial is testing

Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features

Who this might be right for
Bipolar DisorderSchizoaffective Disorder
Melbourne Health 83
Post-approval studies (Phase 4)Study completedNCT00895921
What this trial is testing

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Who this might be right for
Diabetes
Veterans Medical Research Foundation 30
Post-approval studies (Phase 4)Ended earlyNCT01615185
What this trial is testing

A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Kaohsiung Kai-Suan Psychiatric Hospital 96
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Not applicableStudy completedNCT01269710
What this trial is testing

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+8 more
University of North Carolina, Chapel Hill 4
Testing effectiveness (Phase 2)Study completedNCT00733668
What this trial is testing

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca
Not applicableStudy completedNCT02744313
What this trial is testing

MR Imaging of Fat Deposition in Adolescents With First Time Antipsychotic Use

Who this might be right for
Adiposity
Centre for Addiction and Mental Health 17
Early research (Phase 1)Study completedNCT02087579
What this trial is testing

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder+1 more
Janssen Research & Development, LLC 305
Early research (Phase 1)Study completedNCT04922593
What this trial is testing

Relative Bioavailability of LY03010 Compared to Listed Drug

Who this might be right for
SchizophreniaPsychotic DisordersMood Disorders+9 more
Luye Pharma Group Ltd. 281
Early research (Phase 1)Study completedNCT00791232
What this trial is testing

Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Large-scale testing (Phase 3)Study completedNCT01625000
What this trial is testing

Safety and Efficacy of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 512
Not applicableStudy completedNCT03451734
What this trial is testing

Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients

Who this might be right for
SchizophreniaMetabolic Syndrome
Central South University 2,000
Not applicableStudy completedNCT00328952
What this trial is testing

Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia

Who this might be right for
SchizophreniaHallucinations
Seoul National University Hospital 40
Not applicableStudy completedNCT03537040
What this trial is testing

Piloting MOL Intervention for Neuroleptic Decision Making

Who this might be right for
PsychosisMedication Adherence
University of Manchester 5
Not applicableStudy completedNCT01291368
What this trial is testing

Sedation Influence on Delirium and Post-traumatic Stress-disorder as a Result of Hospitalization in Intensive Care

Who this might be right for
DeliriumStress Disorders, Post-Traumatic
University of Aarhus 248
Not applicableStudy completedNCT03692182
What this trial is testing

The Use of Antipsychotics in the Program of All-inclusive Care for the Elderly (PACE)

Who this might be right for
Behavioral and Psychiatric Symptoms of Dementia
Tabula Rasa HealthCare 10,000
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Post-approval studies (Phase 4)Ended earlyNCT02435095
What this trial is testing

Antipsychotic Induced Structural and Functional Brain Changes

Who this might be right for
Schizophrenia
RWTH Aachen University 174
Large-scale testing (Phase 3)Study completedNCT02983188
What this trial is testing

Berberine as Adjuvant Treatment for Schizophrenia Patients

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersMetabolic Syndrome x
The University of Hong Kong 113
Large-scale testing (Phase 3)WithdrawnNCT02212613
What this trial is testing

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Who this might be right for
Major Depressive Disorder and Irritability
Otsuka Pharmaceutical Development & Commercialization, Inc.
Next Page